DK2316466T3 - Præparater af Gram-positive bakterier til behandling af sygdomme, der omfatter en immundysregulering - Google Patents

Præparater af Gram-positive bakterier til behandling af sygdomme, der omfatter en immundysregulering

Info

Publication number: DK2316466T3
Authority: DK; Denmark
Prior art keywords: treatment; positive bacteria; gram; diseases; preparations
Prior art date: 2001-12-11

Application number

DK09075579.4T

Other languages

English (en)

Inventor

Marie-Anne Nahori

Micheline Lagranderie

Gilles Marchal

Bernardo Boris Vargaftig

Jean Lefort

Felix Romain

Georges Hekimian

Philippe Peltre

Original Assignee

Pasteur Institut

Inst Nat Sante Rech Med

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-11

Filing date

2002-12-11

Publication date

2013-11-18

2002-12-11 Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut

2013-11-18 Application granted granted Critical

2013-11-18 Publication of DK2316466T3 publication Critical patent/DK2316466T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Pulmonology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Wood Science & Technology (AREA)
Mycology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Communicable Diseases (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Ophthalmology & Optometry (AREA)
Biochemistry (AREA)
Rheumatology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
General Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)

DK09075579.4T 2001-12-11 2002-12-11 Præparater af Gram-positive bakterier til behandling af sygdomme, der omfatter en immundysregulering DK2316466T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01403195		2001-12-11
EP02804652A EP1461054B1 (en)	2001-12-11	2002-12-11	Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation

Publications (1)

Publication Number	Publication Date
DK2316466T3 true DK2316466T3 (da)	2013-11-18

Family

ID=8183013

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK09075579.4T DK2316466T3 (da)	2001-12-11	2002-12-11	Præparater af Gram-positive bakterier til behandling af sygdomme, der omfatter en immundysregulering
DK02804652.2T DK1461054T3 (da)	2001-12-11	2002-12-11	Gram-positive bakteriepræparater til behandling af sygdomme omfattende en immundysregulering

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK02804652.2T DK1461054T3 (da)	2001-12-11	2002-12-11	Gram-positive bakteriepræparater til behandling af sygdomme omfattende en immundysregulering

Country Status (18)

Country	Link
US (3)	US20060062807A1 (da)
EP (2)	EP2316466B1 (da)
JP (2)	JP4737586B2 (da)
KR (2)	KR101124363B1 (da)
CN (1)	CN1602199B (da)
AT (1)	ATE466585T1 (da)
AU (1)	AU2002356387C1 (da)
BR (1)	BR0214902A (da)
CA (1)	CA2469334C (da)
CY (1)	CY1110727T1 (da)
DE (1)	DE60236318D1 (da)
DK (2)	DK2316466T3 (da)
ES (1)	ES2345188T3 (da)
HK (1)	HK1067073A1 (da)
NZ (2)	NZ533422A (da)
PT (1)	PT1461054E (da)
SI (1)	SI1461054T1 (da)
WO (1)	WO2003049752A2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101124363B1 (ko)	2001-12-11	2012-03-21	앵스티띠 나셔날 드 라 쌍뜨 에 드 라 르셰르슈 메디깔	면역조절곤란증을 포함하는 질병을 치료하기 위한 그람양성균 제제
JP5101795B2 (ja) *	2002-09-06	2012-12-19	ユニヴァーシティカレッジロンドン	免疫モジュレーターとしての全細菌細胞
JP4875494B2 (ja) *	2003-11-14	2012-02-15	ユーシーエルバイオメディカピーエルシー	免疫調節物質
WO2005080414A1 (en)	2004-02-19	2005-09-01	Ramot At Tel-Aviv University Ltd	Peptide mimotopes of mycobacterial mannosylated lipoglycans and uses thereof
JP5070051B2 (ja) *	2004-06-07	2012-11-07	クーバイオロジックスインク．	癌を治療するための細菌組成物
US9107864B2 (en)	2004-06-07	2015-08-18	Qu Biologics Inc.	Tissue targeted antigenic activation of the immune response to treat cancers
US8034359B2 (en)	2004-06-07	2011-10-11	Qu Biologics Inc.	Tissue targeted antigenic activation of the immune response to cancers
US8501198B2 (en)	2004-06-07	2013-08-06	Qu Biologics Inc.	Tissue targeted antigenic activation of the immune response to treat cancers
US8147837B2 (en)	2004-06-24	2012-04-03	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Use of mycobacterial mannosylated lipoglycans peptide mimotopes for treating inflammation
CA2531261A1 (en) *	2005-12-21	2007-06-21	Institut Pasteur	Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
NZ715882A (en) *	2006-10-27	2017-07-28	Qu Biologics Inc	Tissue targeted antigenic activation of the immune response to treat cancers
GB0716778D0 (en) *	2007-08-29	2007-10-10	Bioeos Ltd	Use
EP2087898A1 (en) *	2008-02-06	2009-08-12	Institut Pasteur	A preparation of mycobacterium bovis BCG killed by extended freeze drying (EFD) for treating rheumatoid arthritis
CA2629057A1 (en) *	2008-04-14	2009-10-14	Institut Pasteur	Control of diseases associated with decrease of t-regulatory cells with a preparation of extended freeze-dried killed bacteria
HUP0900231A2 (hu) *	2009-04-16	2010-11-29	Hyd Rakkutato Es Gyogyszerfejlesztoe Kft	Allergiás betegségek kezelésére, gyógyítására alkalmas készítmények és eljárás azok elõállítására
EP2292260A1 (en)	2009-08-13	2011-03-09	Institut Pasteur	Use of mycobacterium bovis BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis
EP2620159A1 (en)	2012-01-24	2013-07-31	Institut Pasteur	Improved cancer treatment by immunotherapy with bcg or antigenically related non-pathogenic mycobacteria
AU2015252726B2 (en)	2014-05-02	2020-12-24	Qu Biologics Inc.	Anti-microbial immunomodulation
EP3419638A4 (en) *	2016-02-25	2019-10-02	Thomas Julius Borody	COMPOSITIONS AND METHOD FOR THE TREATMENT OF CHRONIC INFECTION DISEASES
AU2019361036A1 (en) *	2018-10-17	2021-05-13	SciBac Inc.	Live biotherapeutics to treat and prevent lung conditions
JP7441534B2 (ja) *	2019-01-09	2024-03-01	エムディーヘルスケアインコーポレイテッド	ロドコッカス属細菌由来ナノ小胞およびその用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2594471A (en) *	1946-10-11	1952-04-29	Comb Eng Superheater Inc	Heat exchange apparatus
GB764718A (en) *	1954-08-10	1957-01-02	Glaxo Lab Ltd	Improvements in or relating to freeze-drying processes
GB1027979A (en) *	1963-07-12	1966-05-04	Ciba Ltd	Process for obtaining bcg-cultures
GB1163470A (en) *	1967-11-13	1969-09-04	Cecil Arthur Clark	Improvements in or relating to Adjuvant Vaccines
JPS57186495A (en)	1981-05-14	1982-11-16	Ube Ind Ltd	Preparation of l-alpha-methylphenylalanine
GB8404280D0 (en)	1984-02-17	1984-03-21	Stanford J L	Biological preparations
CA1338879C (en)	1985-05-13	1997-01-28	Commonwealth Scientific And Industrial Research Organisation	Mastitis vaccine
US5075109A (en)	1986-10-24	1991-12-24	Southern Research Institute	Method of potentiating an immune response
JPS63126830A (ja) *	1986-11-17	1988-05-30	Isao Moriya	動植物の体内に抗体を生成する方法
US4897268A (en)	1987-08-03	1990-01-30	Southern Research Institute	Drug delivery system and method of making the same
GB9801870D0 (en) *	1998-01-28	1998-03-25	Raby Limited	Vaccine composition
SE9900495D0 (sv) *	1999-02-12	1999-02-12	Pharmatrix Ab	Vaccine composition
US6350457B1 (en)	1999-06-02	2002-02-26	Genesis Research & Development Corporation Limited	Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
KR101124363B1 (ko)	2001-12-11	2012-03-21	앵스티띠 나셔날 드 라 쌍뜨 에 드 라 르셰르슈 메디깔	면역조절곤란증을 포함하는 질병을 치료하기 위한 그람양성균 제제

2002
- 2002-12-11 KR KR1020117004873A patent/KR101124363B1/ko active IP Right Grant
- 2002-12-11 CA CA2469334A patent/CA2469334C/en not_active Expired - Fee Related
- 2002-12-11 DK DK09075579.4T patent/DK2316466T3/da active
- 2002-12-11 CN CN028247337A patent/CN1602199B/zh not_active Expired - Fee Related
- 2002-12-11 WO PCT/IB2002/005760 patent/WO2003049752A2/en active Application Filing
- 2002-12-11 AT AT02804652T patent/ATE466585T1/de active
- 2002-12-11 DK DK02804652.2T patent/DK1461054T3/da active
- 2002-12-11 NZ NZ533422A patent/NZ533422A/en not_active IP Right Cessation
- 2002-12-11 JP JP2003550801A patent/JP4737586B2/ja not_active Expired - Fee Related
- 2002-12-11 DE DE60236318T patent/DE60236318D1/de not_active Expired - Lifetime
- 2002-12-11 EP EP09075579.4A patent/EP2316466B1/en not_active Expired - Lifetime
- 2002-12-11 AU AU2002356387A patent/AU2002356387C1/en not_active Ceased
- 2002-12-11 SI SI200230916T patent/SI1461054T1/sl unknown
- 2002-12-11 EP EP02804652A patent/EP1461054B1/en not_active Expired - Lifetime
- 2002-12-11 PT PT02804652T patent/PT1461054E/pt unknown
- 2002-12-11 ES ES02804652T patent/ES2345188T3/es not_active Expired - Lifetime
- 2002-12-11 KR KR1020047009081A patent/KR101048798B1/ko not_active IP Right Cessation
- 2002-12-11 NZ NZ555055A patent/NZ555055A/en not_active IP Right Cessation
- 2002-12-11 BR BR0214902-8A patent/BR0214902A/pt not_active IP Right Cessation
- 2002-12-11 US US10/497,703 patent/US20060062807A1/en active Pending
2005
- 2005-01-21 HK HK05100604.3A patent/HK1067073A1/xx not_active IP Right Cessation
2006
- 2006-11-17 US US11/600,907 patent/US7871627B2/en not_active Expired - Fee Related
2009
- 2009-10-21 US US12/582,834 patent/US8404250B2/en not_active Expired - Lifetime
2010
- 2010-08-04 CY CY20101100731T patent/CY1110727T1/el unknown
2011
- 2011-02-03 JP JP2011021856A patent/JP5417354B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CY1110727T1 (el)	2015-06-10
CA2469334A1 (en)	2003-06-19
US20100272756A1 (en)	2010-10-28
DK1461054T3 (da)	2010-08-16
CN1602199B (zh)	2012-04-04
US8404250B2 (en)	2013-03-26
BR0214902A (pt)	2004-11-30
KR20040080434A (ko)	2004-09-18
US7871627B2 (en)	2011-01-18
EP2316466B1 (en)	2013-08-21
WO2003049752A2 (en)	2003-06-19
AU2002356387A1 (en)	2003-06-23
JP2005516915A (ja)	2005-06-09
JP4737586B2 (ja)	2011-08-03
US20060062807A1 (en)	2006-03-23
CN1602199A (zh)	2005-03-30
EP2316466A2 (en)	2011-05-04
KR20110028558A (ko)	2011-03-18
US20070190076A1 (en)	2007-08-16
CA2469334C (en)	2012-05-08
DE60236318D1 (de)	2010-06-17
ES2345188T3 (es)	2010-09-17
HK1067073A1 (en)	2005-04-01
EP1461054B1 (en)	2010-05-05
ATE466585T1 (de)	2010-05-15
AU2002356387B2 (en)	2007-09-13
JP2011121977A (ja)	2011-06-23
AU2002356387C1 (en)	2008-03-06
NZ533422A (en)	2008-03-28
EP1461054A2 (en)	2004-09-29
KR101124363B1 (ko)	2012-03-21
NZ555055A (en)	2010-06-25
PT1461054E (pt)	2010-08-09
SI1461054T1 (sl)	2010-09-30
EP2316466A3 (en)	2012-04-11
KR101048798B1 (ko)	2011-07-15
JP5417354B2 (ja)	2014-02-12
WO2003049752A3 (en)	2003-11-20

Publication	Publication Date	Title
CY1110727T1 (el)	2015-06-10	Παρασκευασματα θετικων κατα gram βακτηριων για τη θεραπεια ασθενειων που περιλαμβανουν μια ανοσολογικη δυσρυθμιση
NO20034056D0 (no)	2003-09-12	Proliferative sykdommer
WO2004069156A3 (en)	2004-09-23	Inactivated probiotic bacteria and methods of use thereof
HK1092467A1 (en)	2007-02-09	N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
WO2003096990A3 (en)	2004-02-26	Protein cages for the delivery of medical imaging and therapy
DE60233801D1 (de)	2009-11-05	Verfahren zur behandlung von gelenkentzündung, schmerzen und mobilitätsverlust
WO2001090129A3 (en)	2002-06-06	Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds
DE60235083D1 (de)	2010-03-04	Substituierte tetracyclin-verbindungen zur behandlung von malaria
WO2005013996A3 (en)	2005-06-09	2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
EP1262177A3 (en)	2003-09-03	Medical use of thyromimetic compounds to treat hair loss and compositions
ATE556706T1 (de)	2012-05-15	Fettalkohol-arzneimittel-konjugate
HK1048831A1 (en)	2003-04-17	Human ctla-4 antibodies and their uses
PL375621A1 (en)	2005-12-12	Pharmaceutical compositions comprising flavonoids and menthol
DK1594833T3 (da)	2008-12-15	1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme
DE69835536D1 (de)	2006-09-21	Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
WO2002078742A3 (en)	2003-03-13	Methods and compositions for treatment of immune dysfunction disorders
WO2003063725A3 (en)	2003-10-30	Methods of preventing and treating flavivirus infection in animals
WO2006004588A3 (en)	2006-05-26	Immunodynamic complexes and methods for using and preparing such complexes
WO2003024996A3 (de)	2004-01-22	Antibakterielle makrozyklen
WO2003013440A3 (en)	2003-07-03	Treatment and prevention of heat shock protein-associated diseases and conditions
ATE458004T1 (de)	2010-03-15	Osteoprotegerin in milch
DK1301637T3 (da)	2008-09-29	DNA-vacciner, der koder for HIV accessoriske proteiner
WO2003026693A3 (en)	2003-12-18	Inhibitors of costimulation by 0x40 and their use against infectious diseases
ATE339899T1 (de)	2006-10-15	Aromakonservierendes mittel
WO2002011549A3 (en)	2002-08-22	Treatment of mycobacterial infection